ETIOPATHOGENETIC ASPECTS OF LIVER DAMAGE IN PATIENTS WITH COVID-19
Abstract
This article discusses epidemiological characteristics, mechanisms of damaging effects, as well as strategies for the management and prevention of liver damage in patients with COVID-19.
References
LITERATURE:
Adams D.H., Hubscher S.G. Systemic viral infections and collateral damagein the liver // Am J Pathol. – 2006. – No. 168 (4). – Р. 1057–1059.
Ali N., Hossain K. Liver injury in severe COVID-19 infection: current insights and challenges // Expert Rev Gastroenterol Hepatol. – 2020. – No. 14 (10). – Р. 879–884.
Bioquard L., Valla D., Rautou P.-E. No evidence for an increased liver uptake of SARS-CoV-2 in metabolic associated fatty liver disease // J. Hepatol. – 2020. – No. 73 (3). – Р. 717–718.
